A multi-institutional team of researchers systematically compared extraction techniques for characterizing plant litter composition that relies on organic matter extraction.
Research identifies the mechanisms through which peptoids affect ions in solution and a mineral surface, increasing the rate of carbonate crystal growth.
A team of researchers from Pacific Northwest National Laboratory and the Environmental Molecular Sciences Laboratory developed a new and flexible software tool called “Advanced Spectra PCA Toolbox.”
PNNL helps deliver efficiency-related rules and requirements that steadily improve performance of America’s buildings, saving energy and costs and reducing carbon emissions.
Mandy Mahoney, director of the DOE Building Technologies Office, visited PNNL in late November. One key agenda item involved meeting with staff for a discussion of effective equity and justice integration in buildings-related research.
Department of Energy’s Advanced Research Projects Agency-Energy selects PNNL project to help accelerate the development of marine carbon dioxide removal technologies.
Leaders from the DOE Office of Energy Efficiency and Renewable Energy visited PNNL October 19–20 for a firsthand look at capabilities and research progress.
PNNL-Sequim scientists will spend the next year testing a new technology that could allow the ocean to soak up more carbon dioxide without contributing to ocean acidification.
Small teams in the Biological Sciences Division at PNNL and at EMSL—the Environmental and Molecular Sciences Laboratory, an Office of Science user facility at PNNL—are pros at preparation.
PNNL’s extensive portfolio of buildings-grid research included three projects that helped answer some of the technical questions related to leveraging energy consumption in buildings to enhance grid operations.
The Northwest Connected Communities Summit brought together representatives of five Department of Energy-funded Connected Communities Projects to share ideas and discuss potential collaboration opportunities.
Data-driven autonomous technology to rapidly design and deliver antiviral interventions targeting SARS-CoV-2 to reduce drug discovery timeline and advance bio preparedness capabilities.